Last reviewed · How we verify

NCT04193072

Imagery Ability in Obstetric Brachial Plexus Palsy

Completed Last updated 29 September 2023
What this trial tests

trial testing Assessment of imagery ability in Brachial Plexus Palsy in 40 participants. Completed in 25 March 2018.

Timeline
2 October 2017
Primary endpoint
27 January 2018
25 March 2018

Quick facts

Lead sponsorIstanbul Medipol University Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment40
Start date2 October 2017
Primary completion27 January 2018
Estimated completion25 March 2018
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul Medipol University Hospital

Who can join

Adults 8 to 18, any sex, with Brachial Plexus Palsy or Image, Body. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Obstetric brachial plexus palsy (OBPP) is the paralysis of the ipsilateral upper extremity after a brachial plexus injury that occurs during labor. Imagery is to rehearse sensorial experiences in the mind such as auditory, visual, tactile, olfactory, gustatory or kinesthetic sensation. Imagery is used as a new technique in rehabilitation recently. Various studies have reported the importance of imagery and using imagery as a rehabilitation technique in different neurologic and orthopedic conditions. This study aimed to evaluate imagery ability in children with OBPP.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Istanbul Medipol University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04193072.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing